Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 204.69 | 214.64 | 203.50 | 211.97 | 644,951 |
| September 15, 2026 | 215.02 | 215.02 | 203.78 | 204.07 | 591,300 |
| September 14, 2026 | 221.93 | 223.29 | 216.00 | 216.58 | 718,800 |
| September 11, 2026 | 212.71 | 229.62 |
Based on reports through December 31, 2025
Axsome develops drugs for the nervous system — depression, narcolepsy, agitation in Alzheimer's disease.
The company's approach is to combine and modify known substances to achieve a new effect with a well-understood safety profile. That is cheaper and faster than searching for a molecule from scratch, but it requires proving the combination is genuinely better than its parts — and patent protection here is more contestable.
Approved drugs for depression and narcolepsy already generate growing revenue, while the main bet is agitation in Alzheimer's disease, a condition with essentially no approved treatment and an enormous burden on carers. Risks: patent disputes with generic makers, trial outcomes and reimbursement. The company pays no dividend.
Address:ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007, US
| 1.2bn |
| PFEPfizer, Inc. | 27.66 | +0.71 % | 992m |
| ABTAbbott Laboratories | 102.56 | +19.50 % | 848m |
| VRTXVertex Pharmaceuticals Incorporated | 514.98 | +33.50 % | 582m |
| BMYBristol-Myers Squibb Company | 62.76 | −1.32 % | 575m |
| 212.44 |
| 220.75 |
| 1m |
| September 10, 2026 | 210.63 | 211.65 | 208.01 | 211.12 | 526,400 |
| September 09, 2026 | 207.97 | 211.22 | 205.76 | 210.63 | 428,400 |
| September 08, 2026 | 205.00 | 210.86 | 202.00 | 207.82 | 385,800 |
| September 04, 2026 | 207.01 | 208.51 | 205.49 | 206.68 | 438,200 |
| September 03, 2026 | 209.32 | 210.59 | 206.60 | 208.35 | 558,800 |
| September 02, 2026 | 203.11 | 210.55 | 201.55 | 209.92 | 608,200 |
| September 01, 2026 | 199.71 | 205.94 | 199.71 | 202.83 | 656,300 |
| August 31, 2026 | 199.00 | 200.74 | 197.05 | 198.52 | 503,700 |
| August 28, 2026 | 205.70 | 205.70 | 199.00 | 199.02 | 441,200 |
| August 27, 2026 | 205.00 | 208.26 | 203.71 | 206.27 | 586,300 |
| August 26, 2026 | 204.48 | 210.68 | 203.70 | 207.15 | 378,400 |
| August 25, 2026 | 207.58 | 209.53 | 200.19 | 205.48 | 731,500 |
| August 24, 2026 | 207.00 | 208.09 | 205.09 | 205.40 | 293,200 |
| August 21, 2026 | 207.22 | 210.87 | 206.50 | 207.77 | 734,900 |
| August 20, 2026 | 216.50 | 217.85 | 206.26 | 208.03 | 620,900 |
| August 19, 2026 | 218.93 | 222.46 | 216.73 | 218.20 | 572,000 |